It is indicated for urinary incontinence, urgency and frequency in unstable bladder conditions due either to idiopathic detrusor instability or neurogenic bladder disorders (detrusor hyperreflexia) in conditions such as spina bifida and multiple sclerosis

Constipation, nausea, dry mouth, diarrhoea, vomiting, abdominal discomfort, anorexia, decreased appetite, dysphagia

Hypersensitivity to oxybutynin or any component, Myasthenia gravis, Narrow-angle glaucoma or shallow anterior chamber, Gastrointestinal obstructive disorders including paralytic ileus, intestinal atony, Patients with severe ulcerative colitis, Patients with bladder outflow obstruction where urinary retention may be precipitated.

This medicine should be used with caution in the frail elderly, patients with Parkinson's disease and children who are at greater risk of occurrence of adverse reactions to the product and in patients with autonomic neuropathy, severe gastro-intestinal motility disorders, hepatic or renal impairment.

Anticholinergic medicinal products may decrease gastrointestinal motility and should be used with caution in patients with gastrointestinal obstructive disorders, intestinal atony and ulcerative colitis.

When oxybutynin is used in high environmental temperatures, this can cause heat prostration due to decreased sweating.

The use of this drug in children under 5 years of age is not recommended; it has not been established whether oxybutynin can be safely used in this age group.

Please consult your doctor when taking this medicine if you are pregnant.

Drugs that may interact with this drug include Amantadine and other anticholinergic antiparkinsonian medicinal products (e.g. biperiden, levodopa), antihistamines, antipsychotics (e.g. phenothiazines, butyrophenones, clozapine), quinidine, digitalis, tricyclic antidepressants, atropine and related compounds like atropinic antispasmodics and dipyridamol